REG-BARCLAYS PLC FORM 8.3 WILLIS TOWERS WATSON PLC - AMENDMENT
26/02/2021 17:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210226:nBwDtjY5a&default-theme=true
FORM 8.3 WILLIS TOWERS WATSON PLC - AMENDMENT
Ap19
FORM 8.3 - Amendments to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 24 February 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,008,821 1.56% 383,054 0.30%
(2) Derivatives (other than options):
153,127 0.12% 203,489 0.16%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
2,168,048 1.68% 592,643 0.46%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 8 226.0612 USD
Purchase 66 228.3700 USD
Purchase 100 226.8700 USD
Purchase 100 226.7000 USD
Purchase 114 225.4900 USD
Purchase 178 226.3001 USD
Purchase 200 225.6350 USD
Purchase 200 226.8225 USD
Purchase 200 227.4900 USD
Purchase 283 226.6499 USD
Purchase 314 226.0568 USD
Purchase 335 225.9044 USD
Purchase 348 227.7356 USD
Purchase 400 225.8800 USD
Purchase 405 226.6279 USD
Purchase 473 226.0395 USD
Purchase 530 226.2854 USD
Purchase 586 226.5040 USD
Purchase 651 227.4323 USD
Purchase 717 227.6329 USD
Purchase 767 226.6650 USD
Purchase 922 226.7571 USD
Purchase 1,084 227.5066 USD
Purchase 1,162 226.5029 USD
Purchase 2,021 226.1699 USD
Purchase 2,358 226.4553 USD
Purchase 2,787 226.8551 USD
Purchase 3,548 226.5841 USD
Purchase 5,025 226.5000 USD
Purchase 5,437 227.2890 USD
Purchase 5,566 225.6400 USD
Purchase 10,290 225.8233 USD
Purchase 10,805 225.7989 USD
Purchase 11,448 227.1611 USD
Purchase 12,534 225.6404 USD
Purchase 13,925 226.1709 USD
Purchase 15,786 226.7549 USD
Purchase 20,377 226.3560 USD
Purchase 30,520 226.1096 USD
Purchase 30,822 226.0334 USD
Purchase 43,008 226.7965 USD
Sale 6 226.5500 USD
Sale 20 226.6400 USD
Sale 33 227.3578 USD
Sale 40 226.9600 USD
Sale 50 227.4500 USD
Sale 58 226.4072 USD
Sale 75 226.9000 USD
Sale 95 226.5171 USD
Sale 114 225.4900 USD
Sale 160 226.6531 USD
Sale 204 226.5760 USD
Sale 206 226.6612 USD
Sale 251 227.4300 USD
Sale 350 227.4314 USD
Sale 487 226.0911 USD
Sale 500 227.0320 USD
Sale 612 227.1880 USD
Sale 767 226.6650 USD
Sale 833 226.6951 USD
Sale 900 226.8922 USD
Sale 966 226.4627 USD
Sale 982 226.6567 USD
Sale 1,170 226.8419 USD
Sale 1,257 226.7492 USD
Sale 1,352 226.6076 USD
Sale 1,500 225.8169 USD
Sale 1,572 226.5502 USD
Sale 2,185 226.7421 USD
Sale 2,355 226.6268 USD
Sale 2,458 226.4721 USD
Sale 2,500 226.6530 USD
Sale 3,594 226.9794 USD
Sale 4,165 226.6215 USD
Sale 5,000 225.3747 USD
Sale 5,040 226.5000 USD
Sale 5,416 225.6300 USD
Sale 5,477 225.6400 USD
Sale 10,365 226.6044 USD
Sale 10,996 227.1485 USD
Sale 12,542 225.6407 USD
Sale 13,584 226.4948 USD
Sale 14,264 226.1574 USD
Sale 14,733 226.0824 USD
Sale 30,000 226.1216 USD
Sale 32,192 226.0584 USD
Sale 45,000 226.8904 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 26 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210226005521/en/
(https://www.businesswire.com/news/home/20210226005521/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Inter-American Dev - Issue of Debt
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement